BALYASNY ASSET MANAGEMENT L.P. - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 214 filers reported holding CANTEL MEDICAL CORP in Q2 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$531,000
-95.0%
6,647
-97.2%
0.00%
-96.1%
Q3 2020$10,535,000
+38.3%
239,767
+39.2%
0.08%
+16.7%
Q2 2020$7,620,000
+643.4%
172,273
+1091.5%
0.07%
+1000.0%
Q4 2019$1,025,000
+327.1%
14,458
+350.0%
0.01%
+200.0%
Q3 2019$240,000
-74.5%
3,213
-66.5%
0.00%
-50.0%
Q2 2018$943,0009,5860.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q2 2020
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,028,295$45,183,00028.17%
NexWave Capital Partners LLC 84,802$3,751,0006.00%
Leonard Green & Partners, L.P. 2,600,000$114,244,0005.94%
Champlain Investment Partners, LLC 3,935,670$172,933,0001.18%
Aurora Investment Counsel 19,848$1,137,0000.94%
Brown Capital Management 2,531,558$111,237,0000.92%
Advantage Alpha Capital Partners LP 73,615$3,235,0000.75%
Conestoga Capital Advisors, LLC 789,154$34,675,0000.70%
WASHINGTON CAPITAL MANAGEMENT, INC 11,000$483,0000.50%
Intrinsic Edge Capital Management LLC 151,077$6,638,0000.45%
View complete list of CANTEL MEDICAL CORP shareholders